Under the settlement, Genevant Sciences and Arbutus Biopharma will grant Moderna a non-exclusive license to their lipid nanoparticle technology for mRNA delivery in infectious disease vaccines. If ...

Grow Therapy's Series D funding was led by TCV and Growth Equity at Goldman Sachs Alternatives, with participation from BCI, ...

Health data company Health Gorilla filed a motion to dismiss a lawsuit from Epic and several healthcare providers alleging ...

The U.S. health insurance industry — a $1.29 trillion giant — is under strain. Soaring healthcare costs, policy shake-ups, and long-standing access gaps are squeezing not just insurers, but the people ...

New research emerged this month shining light on the need for wider use of continuous glucose monitors (CGMs). The study — which was conducted by CCS, a chronic care management company — analyzed data ...

This roundup is published monthly. It is meant to highlight some of healthcare’s recent hiring news and is not intended to be comprehensive. If you have news about an executive appointment, ...

In the past couple of years, payers have come under scrutiny as they increasingly adopt AI tools to automate tasks like the claims review and prior authorization requests. Providers have voiced ...

After Congress failed to pass a funding bill, the government shut down early Wednesday morning, which has significant implications for healthcare, including the future of telehealth flexibilities and ...

For healthcare leaders evaluating procurement options or clinicians recommending at-home care, selecting the right gel pack supplier requires careful evaluation of durability, temperature retention, ...

The FDA turned down an Intercept Pharmaceuticals drug application for the fatty liver disease NASH, a decision that comes nearly three years after the regulator first rejected the molecule. The agency ...

Otsuka Pharmaceutical is broadening its scope in rare disease, striking a deal to acquire Jnana Therapeutics and its lead drug candidate, a small molecule on track for pivotal testing in a metabolic ...

When lung cancer advances after initial lines of therapy, the treatment options dwindle. An AbbVie drug gives patients a new choice as the first FDA-approved treatment for advanced cases of non-small ...